🇺🇸 FDA
Patent

US 9226955

Allogeneic autophagosome-enriched composition for the treatment of disease

granted A61KA61K2039/55522A61K2039/55561

Quick answer

US patent 9226955 (Allogeneic autophagosome-enriched composition for the treatment of disease) held by Providence Health & Services—Oregon expires Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Providence Health & Services—Oregon
Grant date
Tue Jan 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K2039/55522, A61K2039/55561, A61K39/0011, A61K39/001122